New mRNA Cancer Vaccine Passes Important Human Trial

An experimental mRNA cancer-fighting vaccine jointly developed by Moderna and Merck has reportedly succeeded in a Phase II trial. According to the companies, melanoma survivors who received the vaccine in combination with immunotherapy were 44% less likely to have their cancer return or to die…#mrna #phaseii #merckskeytruda #keytruda #modernaandmerck #mrna4157v940 #moderna #hpv #stéphanebancel #merck
Source: Reuters: Health - Category: Consumer Health News Source Type: news